<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Intramyocellular <z:chebi fb="23" ids="18059">lipids</z:chebi> (IMCL) accumulation is a classical feature of <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesised that IMCL accumulate mainly as a consequence of <z:mp ids='MP_0010024'>increased adiposity</z:mp> and independently of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>To test this, we examined IMCL accumulation in two different models and four different populations of participants: muscle biopsies and primary human muscle cells derived from non-<z:mp ids='MP_0001261'>obese</z:mp> and <z:mp ids='MP_0001261'>obese</z:mp> participants with or without type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The mechanism regulating IMCL accumulation was also studied </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Muscle biopsies were obtained from ten non-<z:mp ids='MP_0001261'>obese</z:mp> and seven <z:mp ids='MP_0001261'>obese</z:mp> participants without type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and from eight non-<z:mp ids='MP_0001261'>obese</z:mp> and eight <z:mp ids='MP_0001261'>obese</z:mp> type 2 diabetic patients </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> respiration, <z:chebi fb="2" ids="50744">citrate</z:chebi> synthase activity and both <z:chebi fb="47" ids="16027,28971">AMP</z:chebi>-activated protein kinase and <z:chebi fb="0" ids="15351">acetyl-CoA</z:chebi> carboxylase phosphorylation were measured in muscle tissue </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="23" ids="18059">Lipid</z:chebi> accumulation in muscle and primary myotubes was estimated by Oil Red O staining and fatty acid translocase (FAT)/CD36 localisation by immunofluorescence </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:hpo ids='HP_0001513'>Obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are independently characterised by skeletal muscle IMCL accumulation and permanent FAT/CD36 relocation </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> function is not reduced in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>IMCL accumulation was independent of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in cultured myotubes and was correlated with <z:hpo ids='HP_0001513'>obesity</z:hpo> markers of the donor </plain></SENT>
<SENT sid="10" pm="."><plain>In <z:mp ids='MP_0001261'>obese</z:mp> participants, membrane relocation of FAT/CD36 is a determinant of IMCL accumulation </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS/INTERPRETATION: In skeletal muscle, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function is <z:mpath ids='MPATH_458'>normal</z:mpath> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, while IMCL accumulation is dependent upon <z:hpo ids='HP_0001513'>obesity</z:hpo> or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and is related to sarcolemmal FAT/CD36 relocation </plain></SENT>
<SENT sid="12" pm="."><plain>In cultured myotubes, IMCL content and FAT/CD36 relocation are independent of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, suggesting that distinct factors in <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> contribute to permanent FAT/CD36 relocation ex vivo </plain></SENT>
</text></document>